Pacific Biosciences Of California (PACB) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -562.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -564.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 76.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -31.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -394.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 57.36% |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | -335.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -335.73% |
| Dec 31, 2025 | 130.78% |
| Sep 30, 2025 | 107.71% |
| Jun 30, 2025 | -118.26% |
| Mar 31, 2025 | 103.04% |
| Dec 31, 2024 | 89.01% |
| Sep 30, 2024 | -112.24% |
| Jun 30, 2024 | 115.46% |
| Mar 31, 2024 | -459.25% |
| Dec 31, 2023 | -1,096.02% |
| Sep 30, 2023 | 3,033.48% |
| Jun 30, 2023 | -20.48% |
| Mar 31, 2023 | 190.50% |
| Dec 31, 2022 | -41.60% |
| Jun 30, 2022 | 74.58% |
| Mar 31, 2022 | -103.73% |
| Dec 31, 2021 | 169.60% |
| Jun 30, 2021 | -1,720.29% |
| Mar 31, 2021 | 2,068.44% |
| Dec 31, 2020 | 479.49% |
| Sep 30, 2020 | 842.26% |
| Jun 30, 2020 | -211.73% |
| Mar 31, 2020 | 102.65% |
| Dec 31, 2019 | 82.01% |
| Sep 30, 2019 | -81.83% |
| Jun 30, 2019 | -247.79% |
| Mar 31, 2019 | 116.30% |
| Dec 31, 2018 | -103.94% |
| Sep 30, 2018 | 242.27% |
| Jun 30, 2018 | -132.02% |
| Mar 31, 2018 | -26.73% |
| Dec 31, 2017 | -56.31% |
| Sep 30, 2017 | -431.60% |
| Jun 30, 2017 | 59.56% |
| Mar 31, 2017 | 190.17% |
| Dec 31, 2016 | -193.90% |
| Sep 30, 2016 | -255.24% |
| Jun 30, 2016 | 208.22% |
| Mar 31, 2016 | -119.31% |
| Dec 31, 2015 | 518.59% |
| Sep 30, 2015 | -82.28% |
| Jun 30, 2015 | 66.76% |
| Mar 31, 2015 | -141.47% |
| Dec 31, 2014 | 102.70% |
| Sep 30, 2014 | -69.87% |
| Jun 30, 2014 | -7.01% |
| Mar 31, 2014 | 129.29% |
| Dec 31, 2013 | -374.67% |
| Sep 30, 2013 | 2,347.32% |
| Jun 30, 2013 | 46.08% |
| Mar 31, 2013 | 349.44% |
| Dec 31, 2012 | 988.09% |
| Sep 30, 2012 | -134.74% |
| Jun 30, 2012 | 24.80% |
| Mar 31, 2012 | 95.87% |
| Dec 31, 2011 | -98.49% |
| Sep 30, 2011 | 111.18% |